ArticleCytotherapy2021

A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications.

Heather Kavanagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.